BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Janicko M, Drazilova S, Pella D, Fedacko J, Jarcuska P. Pleiotropic effects of statins in the diseases of the liver. World J Gastroenterol 2016; 22(27): 6201-6213 [PMID: 27468210 DOI: 10.3748/wjg.v22.i27.6201]
URL: https://www.wjgnet.com/1007-9327/full/v22/i27/6201.htm
Number Citing Articles
1
Sean Sileno, Razvan M. Chirila, Dana M. Harris. Use of statins, amiodarone, direct oral anticoagulants and NSAIDs in chronic liver disease: a guide for general cliniciansRomanian Journal of Internal Medicine 2020; 58(4): 181 doi: 10.2478/rjim-2020-0018
2
Andrea Dalbeni, Rosanna Villani, Michele Bevilacqua, Federica Sacco, Diego Faccincani, Filippo Cattazzo, Francesco Cavallone, Anna Mantovani, Vittoria Ceruti, Donatella Ieluzzi, Veronica Paon, Alessandro Mantovani, Gaetano Serviddio, David Sacerdoti. Effects of direct‐acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: A real‐life Italian experienceJournal of Digestive Diseases 2022; 23(5-6): 324 doi: 10.1111/1751-2980.13103
3
Christa Buechler, Charalampos Aslanidis. Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinomaBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2020; 1865(5): 158658 doi: 10.1016/j.bbalip.2020.158658
4
Tawfik Khoury, Amir Mari, Hana Amara, Mohamed Jabaren, Abdulla Watad, Wiliam Nseir, Wisam Sbeit, Mahmud Mahamid. Impact of Chronic Statins Use on the Development of Esophagitis in Patients with Gastroesophageal Reflux DiseaseCanadian Journal of Gastroenterology and Hepatology 2019; 2019: 1 doi: 10.1155/2019/6415757
5
Chalermrat Bunchorntavakul, K. Rajender Reddy. Pharmacologic Management of Portal HypertensionClinics in Liver Disease 2019; 23(4): 713 doi: 10.1016/j.cld.2019.06.004
6
Niki Katsiki, Vasilios G Athyros. Non-alcoholic steatohepatitis and type 2 diabetes mellitus: the effects of weight loss versus drug treatmentCurrent Medical Research and Opinion 2019; 35(7): 1305 doi: 10.1080/03007995.2019.1589152
7
H. A. Elmekawy, F. Belal, A. E. Abdelaziz, K. S. Abdelkawy, A. A. Ali, F. Elbarbry. Pharmacokinetic interaction between atorvastatin and fixed-dose combination of sofosbuvir/ledipasvir in healthy male Egyptian volunteersEuropean Journal of Clinical Pharmacology 2021; 77(9): 1369 doi: 10.1007/s00228-021-03130-z
8
Xin Ding, Xu He, Bulang Tang, Tian Lan. Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategiesChinese Medicine 2024; 19(1) doi: 10.1186/s13020-024-00894-1
9
V. Ye. Molodtsov, O. I. Fediv, G. Ya. Stupnytska. ЕФЕКТИВНІСТЬ ЗАСТОСУВАННЯ АТОРВАСТАТИНУ ПРИ ПОЄДНАННІ АЛКОГОЛЬНОЇ ХВОРОБИ ПЕЧІНКИ ТА АРТЕРІАЛЬНОЇ ГІПЕРТЕНЗІЇЗдобутки клінічної і експериментальної медицини 2020; (2): 126 doi: 10.11603/1811-2471.2020.v.i2.11188
10
Abdolkhaleg Deezagi, Naser Safari. Rosuvastatin inhibit spheroid formation and epithelial–mesenchymal transition (EMT) in prostate cancer PC-3 cell lineMolecular Biology Reports 2020; 47(11): 8727 doi: 10.1007/s11033-020-05918-1
11
Sylvia Drazilova, Jakub Gazda, Martin Janicko, Peter Jarcuska. Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA TherapyCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/6150861
12
Peter Jarcuska, Ahmed Abdel-Razik, Robert Flisiak, Ram B. Singh. Chronic Viral Hepatitis and Metabolic Syndrome/Cardiovascular RiskCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/7369314
13
Doris Ogresta, Anna Mrzljak, Maja Cigrovski Berkovic, Ines Bilic-Curcic, Sanja Stojsavljevic-Shapeski, Lucija Virovic-Jukic. Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic ImplicationsJournal of Clinical and Translational Hepatology 2022; 10(2): 339 doi: 10.14218/JCTH.2021.00268
14
Narendra S. Choudhary, Sanjiv Saigal, Neeraj Saraf, Arvinder S. Soin. Acute Onset Significant Muscle Weakness in a Patient Awaiting Liver Transplantation: Look for StatinsJournal of Clinical and Experimental Hepatology 2017; 7(1): 66 doi: 10.1016/j.jceh.2016.09.007
15
Ruirui Feng, Xiaozhong Guo, Yun Kou, Xiangbo Xu, Cen Hong, Wenwen Zhang, Yang An, Cyriac Abby Philips, Andrea Mancuso, Xingshun Qi. Association of lipid profile with decompensation, liver dysfunction, and mortality in patients with liver cirrhosisPostgraduate Medicine 2021; 133(6): 626 doi: 10.1080/00325481.2021.1930560
16
Pamela S. Tietz-Bogert, Minsuk Kim, Angela Cheung, James H. Tabibian, Julie K. Heimbach, Charles B. Rosen, Madhumitha Nandakumar, Konstantinos N. Lazaridis, Nicholas F. LaRusso, Jaeyun Sung, Steven P. O’Hara. Metabolomic Profiling of Portal Blood and Bile Reveals Metabolic Signatures of Primary Sclerosing CholangitisInternational Journal of Molecular Sciences 2018; 19(10): 3188 doi: 10.3390/ijms19103188
17
Haiyan Zhou, Maeda Toshiyoshi,, Wenli Zhao, Ye Zhao, Yan Zhao. Statins on nonalcoholic fatty liver disease: A systematic review and meta-analysis of 14 RCTsMedicine 2023; 102(26): e33981 doi: 10.1097/MD.0000000000033981
18
Fabio Nascimbeni, Elisa Pellegrini, Simonetta Lugari, Alberto Mondelli, Serena Bursi, Giovanna Onfiani, Francesca Carubbi, Amedeo Lonardo. Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foesAtherosclerosis 2019; 284: 66 doi: 10.1016/j.atherosclerosis.2019.02.028
19
Stuart McPherson, Shion Gosrani, Sarah Hogg, Preya Patel, Aaron Wetten, Rachael Welton, Kate Hallsworth, Matthew Campbell. Increased cardiovascular risk and reduced quality of life are highly prevalent among individuals with hepatitis CBMJ Open Gastroenterology 2020; 7(1): e000470 doi: 10.1136/bmjgast-2020-000470
20
Hui Li. Intercellular crosstalk of liver sinusoidal endothelial cells in liver fibrosis, cirrhosis and hepatocellular carcinomaDigestive and Liver Disease 2022; 54(5): 598 doi: 10.1016/j.dld.2021.07.006
21
Urša Kovač, Cene Skubic, Laura Bohinc, Damjana Rozman, Tadeja Režen. Oxysterols and Gastrointestinal Cancers Around the ClockFrontiers in Endocrinology 2019; 10 doi: 10.3389/fendo.2019.00483
22
Anne Noom, Birgit Sawitzki, Petra Knaus, Georg N. Duda. A two-way street – cellular metabolism and myofibroblast contractionnpj Regenerative Medicine 2024; 9(1) doi: 10.1038/s41536-024-00359-x
23
Yi-Hao Yen, Kwong-Ming Kee, Chien-Hung Chen, Tsung-Hui Hu, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Tatsuo Kanda. Sustained virological response and metabolic risk factors are associated with mortality in patients with chronic hepatitis CPLOS ONE 2019; 14(1): e0208858 doi: 10.1371/journal.pone.0208858
24
Francisco J. Zapatero-Belinchón, Rina Ötjengerdes, Julie Sheldon, Benjamin Schulte, Belén Carriquí-Madroñal, Graham Brogden, Laura M. Arroyo-Fernández, Florian W. R. Vondran, Benjamin Maasoumy, Thomas von Hahn, Gisa Gerold. Interdependent Impact of Lipoprotein Receptors and Lipid-Lowering Drugs on HCV InfectivityCells 2021; 10(7): 1626 doi: 10.3390/cells10071626
25
Yue Chang, Qinyu Liu, Zidong Zhou, Yuping Ding, Mei Yang, Wei Xu, Kai Chen, Qing Zhang, Zhenguo Wang, Hai Li. Can Statin Treatment Reduce the Risk of Hepatocellular Carcinoma? A Systematic Review and Meta-AnalysisTechnology in Cancer Research & Treatment 2020; 19 doi: 10.1177/1533033820934881
26
Myung Ji Goh, Dong Hyun Sinn. Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?Clinical and Molecular Hepatology 2022; 28(3): 380 doi: 10.3350/cmh.2021.0366
27
Yi-Hsuan Wei, Shu-Lang Liao, Sen-Hsu Wang, Chia-Chun Wang, Chang-Hao Yang. Simvastatin and ROCK Inhibitor Y-27632 Inhibit Myofibroblast Differentiation of Graves’ Ophthalmopathy-Derived Orbital Fibroblasts via RhoA-Mediated ERK and p38 Signaling PathwaysFrontiers in Endocrinology 2021; 11 doi: 10.3389/fendo.2020.607968
28
Elias Khajeh, Arash Dooghaie Moghadam, Pegah Eslami, Sadeq Ali-Hasan-Al-Saegh, Ali Ramouz, Saeed Shafiei, Omid Ghamarnejad, Sepehr Abbasi Dezfouli, Christian Rupp, Christoph Springfeld, Carlos Carvalho, Pascal Probst, Seyed Mostafa Mousavizadeh, Arianeb Mehrabi. Statin use is associated with the reduction in hepatocellular carcinoma recurrence after liver surgeryBMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09192-1
29
Christopher Kasia, Steven J. Scaglione. Patients With Chronic Liver Disease/Cirrhosis Should Not Take Statin MedicationsClinical Liver Disease 2019; 13(4): 106 doi: 10.1002/cld.788
30
Dominik Safcak, Sylvia Drazilova, Jakub Gazda, Igor Andrasina, Svetlana Adamcova-Selcanova, Radovan Barila, Michal Mego, Marek Rac, Lubomir Skladany, Miroslav Zigrai, Martin Janicko, Peter Jarcuska. Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: Clinical Patterns, Outcomes, and Prognostic Factors for Overall Survival—A Retrospective Analysis of a Slovak CohortJournal of Clinical Medicine 2021; 10(14): 3186 doi: 10.3390/jcm10143186
31
Zahid Ijaz Tarar, Umer Farooq, Faisal Inayat, Sanket D Basida, Faisal Ibrahim, Mustafa Gandhi, Gul Nawaz, Arslan Afzal, Ammad J Chaudhary, Faisal Kamal, Ahmad H Ali, Yezaz A Ghouri. Statins decrease the risk of hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysisWorld Journal of Experimental Medicine 2024; 14(4): 98543 doi: 10.5493/wjem.v14.i4.98543
32
Sneha Kothari, Hiteshi Dhami-Shah, Samir R. Shah. Antidiabetic Drugs and Statins in Nonalcoholic Fatty Liver DiseaseJournal of Clinical and Experimental Hepatology 2019; 9(6): 723 doi: 10.1016/j.jceh.2019.06.003
33
Sura Salman Ejam, Raed Obaid Saleh, Maria Jade Catalan Opulencia, Mazin AA Najm, Aziza Makhmudova, Abduladheem Turki Jalil, Walid Kamal Abdelbasset, Moaed E Al-Gazally, Ali Thaeer Hammid, Yasser Fakri Mustafa, Sergushina Elena Sergeevna, Sajad Karampoor, Rasoul Mirzaei. Pathogenic Role of 25-Hydroxycholesterol in Cancer Development and ProgressionFuture Oncology 2022; 18(39): 4415 doi: 10.2217/fon-2022-0819
34
Antonio Magan-Fernandez, Manfredi Rizzo, Giuseppe Montalto, Giulio Marchesini. Statins in liver disease: not only prevention of cardiovascular eventsExpert Review of Gastroenterology & Hepatology 2018; 12(8): 743 doi: 10.1080/17474124.2018.1477588
35
Daniela M. Santos, Lorena Pantano, Gina Pronzati, Paula Grasberger, Clemens K. Probst, Katharine E. Black, Jillian J. Spinney, Lida P. Hariri, Royale Nichols, Yufei Lin, Michael Bieler, Peter Seither, Paul Nicklin, David Wyatt, Andrew M. Tager, Benjamin D. Medoff. Screening for YAP Inhibitors Identifies Statins as Modulators of FibrosisAmerican Journal of Respiratory Cell and Molecular Biology 2020; 62(4): 479 doi: 10.1165/rcmb.2019-0296OC
36
Armita M. Gorabi, Nasim Kiaie, Vanessa Bianconi, Tannaz Jamialahmadi, Khalid Al-Rasadi, Thomas P. Johnston, Matteo Pirro, Amirhossein Sahebkar. Antiviral effects of statinsProgress in Lipid Research 2020; 79: 101054 doi: 10.1016/j.plipres.2020.101054
37
Mazaher Ahmadi, Shayan Amiri, Stevan Pecic, Filip Machaj, Jakub Rosik, Marek J. Łos, Javad Alizadeh, Reza Mahdian, Simone C. da Silva Rosa, Dedmer Schaafsma, Shahla Shojaei, Tayyebeh Madrakian, Amir A. Zeki, Saeid Ghavami. Pleiotropic effects of statins: A focus on cancerBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020; 1866(12): 165968 doi: 10.1016/j.bbadis.2020.165968
38
Mudassar Aleem, Alina Zainab, Azfar Hameed, Abdul Basit Khan, Syed Zahid Ali, Shifa Younus. Comparison of the Efficacy of Rosuvastatin 5 mg and 10 mg in Patients of Type 2 Diabetes Mellitus With DyslipidemiaCureus 2022;  doi: 10.7759/cureus.22595
39
K.S. Abdelkawy, Fathalla Belal, AbdelazizE Abdelaziz, H. A. Elmekawy, M. Y. Abdelgaied, N. M. El-Khodary. Statins Increase the Bioavailability of Fixed-Dose Combination of Sofosbuvir/Ledipasvir by Inhibition of P-glycoproteinDrug Research 2022; 72(06): 319 doi: 10.1055/a-1835-1690
40
SK Jha, K Saharawat, R Keshari, P Jha, S Purkayastha, R Ranjan. Addition of Simvastatin to Carvedilol and Endoscopic Variceal Ligation improves rebleeding and survival in patients with Child-Pugh A and B class but not in Child Pugh C classAnnals of Clinical Gastroenterology and Hepatology 2019; 3(1): 020 doi: 10.29328/journal.acgh.1001010